DIN 02231209 — HYDROXYZINE HYDROCHLORIDE INJECTION, USP 50 MG
HYDROXYZINE HYDROCHLORIDE INJECTION, USP is a solution of Hydroxyzine marketed by STERIMAX INC. The full Hydroxyzine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02231209
- Brand name
- HYDROXYZINE HYDROCHLORIDE INJECTION, USP
- Active ingredient
- Hydroxyzine
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- STERIMAX INC
- Health Canada status
- DORMANT
- Drug class
- Antihistamine (anxiolytic / antipruritic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydroxyzine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00024694 | ATARAX | 10 MG | SYRUP | SEARCHLIGHT PHARMA INC | MARKETED |
| 00646059 | HYDROXYZINE | 10 MG | CAPSULE | AA PHARMA INC | MARKETED |
| 00646024 | HYDROXYZINE | 25 MG | CAPSULE | AA PHARMA INC | MARKETED |
| 00646016 | HYDROXYZINE | 50 MG | CAPSULE | AA PHARMA INC | MARKETED |
| 00742813 | HYDROXYZINE HYDROCHLORIDE INJECTION USP | 50 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 00738824 | NOVO-HYDROXYZIN | 10 MG | CAPSULE | TEVA CANADA LIMITED | DORMANT |
| 00738832 | NOVO-HYDROXYZIN | 25 MG | CAPSULE | TEVA CANADA LIMITED | DORMANT |
| 00738840 | NOVO-HYDROXYZIN | 50 MG | CAPSULE | TEVA CANADA LIMITED | DORMANT |